Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Healthy Subject 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Tamoxifen 2Specimen Handling 2Neoadjuvant Therapy 2poly ICLC 1pasireotide 1liposomal doxorubicin 1exemestane 1Vorinostat 1UAB 30 1Surgical Procedures, Operative 1Sulindac 1Selective Estrogen Receptor Modulators 1Ritonavir 1Petrolatum 1Letrozole 1Immunohistochemistry 1Granulocyte-Macrophage Colony-Stimulating Factor 1Colony-Stimulating Factors 1Biopsy 1Bexarotene 1Atorvastatin 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Carcinoma, Intraductal, Noninfiltrating × UAB 30 × Clear all
NCT02876640 2024-06-18

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

National Cancer Institute (NCI)

Phase 1 Terminated
27 enrolled 21 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡